Biostar Pharmaceuticals, Inc.
BSPM · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | $0 | $0 | -$0 |
| % Margin | – | – | – | -11.6% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 1,992.8% |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | – | – | – | 1,066.1% |
| EPS Diluted | -0.05 | -0.5 | -0.38 | 1.61 |
| % Growth | 90% | -31.6% | -123.6% | – |
| Operating Cash Flow | -$0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | $0 | $0 |